NL-OMON33361已完成不适用
Tailored treatment of prostate cancer by biomarkers: PROCABIO - PROCABIO
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Patients who decide to participate in PRIAS or are participating in PRIAS for less than 2 years are eligible. The inclusion criteria for PRIAS are the following:
- •1. Histologically proven adenocarcinoma of the prostate
- •2. Men should be fit for curative treatment
- •3. PSA-level at diagnosis <= 10 ng/mL
- •4. PSA density (PSA D) less than 0,2
- •5. Clinical stage T1C or T2
- •6. Adequate biopsy sampling (see 'biopsy protocol')
- •7. Gleason score 3+3=6
- •8. One or 2 biopsy cores invaded with prostate cancer
- •9. Participants must be willing to attend the follow-up visits
排除标准
- •The exclusion criteria for PRIAS are the following:
- •1. Men who can not or do not want to be irradiated or operated
- •2. A former therapy for prostate cancer
研究者
相似试验
招募中
不适用
Clinical study of prostate cancer dagnositic makers using genetic polymorphismsProstate cancerJPRN-UMIN000019278Kyoto University2,000
已完成
不适用
Improving cancer targeting accuracy in prostate radiotherapy with SeedTracker real-time image guidance system- A Phase I studyCancer - ProstateProstate CancerACTRN12618001421224iverpool Hospital Cancer Therapy30
招募中
2 期
Primary focal therapy for prostate cancer using low-dose-rate brachytherapyprostate cancerJPRN-UMIN000050997Saitama Cancer Center200
招募中
不适用
Personalizing therapy of urogenital cancer by metastatic tissue Immune profiling, Organoid culture, and NExt genERation sequencingUrigenital cancerbladder cancer and prostate cancer10038364NL-OMON46194Radboud Universitair Medisch Centrum150
招募中
2 期
Salvage focal therapy for prostate cancer using low-dose-rate brachytherapyprostate cancerJPRN-UMIN000051113Saitama Cancer Center100